WeDoctor Poised to Float IPO in H2 2021, Backed by Tencent
• WeDoctor, a Chinese online healthcare services provider, is set to float its Initial Public Offering (IPO) by H2 2021.
• The firm is considering either a Hong Kong or US listing and that the plans from the firm could change over time.
• WeDoctor is transforming access to medicine in an innovative digital manner, and is backed by Tencent.
Chinese online healthcare services provider, WeDoctor, is looking to float its Initial Public Offering (IPO) by the second half (H2) of this year. WeDoctor has been in talks with investors and financial advisors about the IPO and is considering either a Hong Kong or US listing, with the plans from the firm possibly changing over time.
WeDoctor is looking to capitalize on the Chinese government’s easing of its crackdown on top tech companies, and launch its IPO at the perfect window. The company, founded in 2010 in Hangzhou China, is transforming access to medicine in an innovative digital manner. WeDoctor connects more than 3000 hospitals, 300,000 doctors, and 200 million patients together.
WeDoctor is backed by Tencent and has become a major player in the telemedicine sector in China. The company’s previous attempt to float its IPO was thwarted by the Chinese government’s crackdown on homegrown tech companies prevalent at the time. Now, WeDoctor is looking to take advantage of the new landscape and launch its IPO by H2 of 2021.
WeDoctor’s IPO would be a major milestone for the company and its investors, and would open up a new avenue of growth and potential for the company. WeDoctor’s unique digital platform has made it a leader in the healthcare sector in China, and a successful IPO could propel the company to the next level.